To investigate the possible mutations in the carbohydrate sulfotransferase 6 (CHST6) gene of 2 unrelated cases of macular corneal dystrophy (MCD) and to report atypical stromal deposits in one of them.
M acular corneal dystrophy (MCD) is an autosomal recessive stromal dystrophy, which was previously known as Groenouw corneal dystrophy type II. The condition is characterized by bilateral corneal clouding and central corneal thinning. 1 Signs of disease include irregularly shaped whitish stromal deposits that appear progressively elevated with diffuse stromal haze extending to the limbus. The corneal endothelium can be affected at advanced stages with formation of guttae and stromal thickening. Visual impairment because of stromal opacities usually starts in the second to third decades of life, and occasionally, patients may suffer from recurrent epithelial erosions or photophobia.
The carbohydrate sulfotransferase 6 (CHST6) gene on chromosome 16q22, which encodes N-acetylglucosamine 6-O-sulfotransferase, has been identified as the diseasecausing gene for MCD. 2 Mutations in CHST6 gene result in improper sulfation of keratan sulfate (KS), a major glycosaminoglycan of the cornea. 3 Based on the immunoreactivity of the macular deposits with a monoclonal antibody (5D4 anti-KS antibody) specific for the sulfated epitopes of KS, MCD has been classified into 3 subtypes. 4, 5 In MCD type I, there is no immunoreactivity seen in the cornea and very little to no reactivity seen in the serum. In MCD type IA, only the keratocytes are stained by 5D4 antibody and there is very little or no reactivity seen in the serum and corneal stroma. In MCD type II, normal to subnormal sulfated KS levels in the serum are found, along with immunoreactivity with sulfated KS in the stromal deposits, keratocytes, Descemet membrane, and endothelial cells. However, these 3 subtypes are clinically indistinguishable from one another. Herein, we describe 2 unique and unrelated cases of MCD, each with a novel mutation in the CHST6 gene.
PATIENT AND METHODS

Clinical History Case 1
A 40-year-old Vietnamese man with a history of bilateral decreased vision and painful recurrent corneal erosions was seen at the Ho Chi Minh City Eye Hospital, Vietnam. Both corneas showed indiscrete stromal aggregates and diffusely dense corneal haze throughout the stroma. There 
Case 2
A 38-year-old African American woman presented to Washington University Eye Center with decreased vision and severe photophobia in both eyes. In addition to clinical symptoms of recurrent corneal erosions in both eyes, the patient was noted to have mild central corneal thinning with central corneal thickness of 474 and 495 mm for the right and left eyes, respectively. Multiple nummular stromal deposits at various depths of the corneal stroma were noted in both corneas. Moderate stromal haze extending to the limbus was noted in the intervening spaces between the deposits ( Fig. 1 ). There were scattered and subtle endothelial guttae without evident corneal edema. There was no known history of corneal disease or known systemic hereditary diseases in the immediate family members. Under the working clinical diagnosis of MCD, the patient underwent deep anterior lamellar keratoplasty in the left eye for visual rehabilitation.
The study adheres to the tenets of the Declaration of Helsinki. The retrospective review was approved by the Institutional Review Boards of the Washington University and the Eye Hospital of Ho Chi Minh City, Vietnam, respectively. Informed consent was also obtained from each patient for further gene analysis and histopathological examination. Both excised corneal specimens after keratoplasty were fixed in 10% buffered formalin and submitted to the Department of Pathology, Washington University, Saint Louis, MO, for pathological examination. Corneal specimens were subsequently embedded in paraffin, and tissue sections of 5-mm thickness were then stained with various histochemical dyes.
Laboratory Studies
Staining for sulfated KS and gene sequencing of CHST6 was conducted at the Cornea Research Lab of Washington University. Because case 1 was initially diagnosed with stromal dystrophy, a blood sample was submitted to the John and Marcia Carver Nonprofit Genetic Testing Laboratory at the University of Iowa for genotyping for possible mutations in transforming growth factor beta 1-induced protein (TGFBIp) coding gene.
To detect the presence of sulfated KS, immunofluorescence staining was carried out on deparaffinized and hydrated tissue sections by incubation with a mouse monoclonal antibody against sulfated KS (5D4; Seikagaku Corporation, Tokyo, Japan) and an AlexaFluor 633-conjugated goat antimouse IgG secondary antibody (Invitrogen, Carlsbad, CA). To detect TGFBIp, a rabbit antihuman TGFBIp antibody (Proteintech Group, Chicago, IL) and an AlexaFluor 633 goat antirabbit IgG secondary antibody (Invitrogen) were used. Thioflavin-T (ThT) was used to detect amyloid deposits.
For mutational analyses, DNA was isolated from the patients' blood using a DNA extraction kit (DNeasy; Qiagen, Inc, Valencia, CA), according to the manufacturer's protocols. The coding region of the CHST6 gene was amplified by polymerase chain reaction (PCR). Each PCR reaction was carried out in a 40-mL reaction mixture containing genomic DNA (25-40 ng), primers (2 ng/mL each), Taq DNA polymerase (0.1 mL; Invitrogen), MgCl 2 (1.5 mM), dNTPs (0.2 mM each), and 13 PCR buffer (provided with Taq polymerase). Amplification reactions were performed under the following conditions: 2 minutes of denaturation at 96°C, followed by 35 cycles of denaturation at 96°C, annealing at 55 or 57°C, and extension at 72°C, for 30 seconds each, followed by further extension at 72°C for 5 minutes. The following primer sets, designed by Akama et al, 2 were used: for the 5'-coding region, CK71h-intrn (5'-GC CCCTAACCGCTGCGCTCTC-3') and CK71h-R1180 (5'-GGC TTGCACACGGCCTCGCT-3'); for the middle coding region, CK71h-F1041 (5'-GACGTGTTTGATGCCTATCTGCCTTG-3') and CK71h-R1674 (5'-CGGCGCGCACCAGGTCCA-3'); and for the 3'-coding region, CK71h-F1355 (5'-CTCCCGG GAGCAGACAGCCAA-3') and CK71h-R1953 (5'-CTCCCG GGCCTAGCGCCT-3'). Another pair of primers designed by El-Ashry et al 6 was also used for amplification: CK71M-F1 (5'-GACATGGACGTGTTTGATGC-3') and CK71M-R2 (5'-ATCCGTGGGTGATGTTATGG-3'). For direct sequencing, PCR products were purified from a 1% agarose gel using the Qiaquick purification kit (Qiagen, Inc), and sequencing reactions were carried out with the same primers as those used for amplification, along with 2 other primers designed by El-Ashry et al 6 : CK71M-R1 (5'-GCACGATGCCGTTGTCAC-3') and CK71M-F2 (5'-GCTCAACCTACGCATCGTG-3'). 6 Sequencing reactions were carried out in forward and reverse directions for 60 cycles at 95°C for 10 seconds for denaturation, at 50°C for 5 seconds for annealing, and at 60°C for 4 minutes for extension, with the Terminator BigDye 3.1 sequencing reagent (Applied Biosystems). Automated DNA sequencing was then performed on the reaction products using the Applied Biosystems 3730 DNA sequencer (Applied Biosystems) by the Protein and Nucleic Acid Chemistry Laboratory at the Washington University School of Medicine.
RESULTS
Histochemical staining of tissue sections from case 1 are shown in Figure 2 . In the section stained with hematoxylin and eosin, both the stromal (indicated by ** in Fig. 2 ) and epithelial regions (indicated by * in Fig. 2 ) of these lesions contain deposits that stain with eosin ( Fig. 2A) . Staining with alcian blue revealed the presence of classic mucopolysaccharide accumulations in the stroma, supporting a diagnosis of MCD (Fig. 2B ). In addition to these small and evenly distributed stromal deposits, we observed large alcian bluestained deposits in some areas of the anterior stroma (Fig. 2B , indicated by **). Most interestingly, in other regions of the central cornea, we also observed some deposits in the anterior stroma extending profusely into the epithelial layer of the cornea. Although most of the superficial stromal component of this lesion stained with alcian blue (Fig. 2B ), there were a few deposits that stained with Masson trichrome in the subepithelial region (Fig. 2C ) and within the large alcian bluepositive aggregates (Fig. 2B ). TGFBIp was found to be present in the larger aggregates in the superficial stroma ( Fig. 2D , in green) and throughout the lamellae of the stroma, which is also FIGURE 2 . Histological studies of paraffin sections from the cornea of case 1 stained with hematoxylineosin (A), alcian blue (B), and Masson trichrome (C) and immunofluorescent image of cornea stained with TGFBI antibody (green), ThT for amyloid (red), and nuclear stain SYTOX Orange (blue) (D). Alcian blue staining shows the presence of acid mucopolysaccharides in the large superficial stromal aggregate (depicted by ** in B). Masson trichrome staining shows the presence of hyaline material in both the subepithelial (depicted by * in C) and superficial stromal regions (depicted by ** in C). ThT staining shows the presence of amyloid in the large superficial stromal aggregate (depicted by ** in D). TGFBI is noted throughout the stroma, similar to normal tissue (not shown). 340) . B, Note the slightly basophilic deposits beneath the Bowman layer in the anterior stroma (arrows, magnification, 3400). C, Deposits stain positive for alcian blue throughout the corneal stroma, confirming the diagnosis of MCD (magnification, 340). D, Higher magnification demonstrates that prominent alcian bluepositive deposits are present in the subepithelial layer and the anterior stroma (top arrow), but less conspicuous interlamellar deposits can also be seen throughout the stroma (lower arrow, magnification, 3200). found in the normal cornea (data not shown). However, we also consistently observed some amyloid deposits by ThT within the larger anterior stromal aggregates in multiple tissue sections (Fig. 2D, in red) .
Histochemical staining of corneal sections from case 2 with alcian blue also revealed the presence of multiple subepithelial and intrastromal mucopolysaccharide deposits. This data confirms the diagnosis of MCD (Figs. 3C, D) .
On staining the corneal sections of case 1 with the 5D4 anti-KS antibody, only the keratocytes in the stroma showed the presence of sulfated KS (Fig. 4, in green) , along with minor staining of select endothelial cells. The extracellular stromal matrix and the Descemet membrane, however, did not stain for sulfated KS. These findings suggest that case 1 is consistent with MCD type IA. Control normal corneal section from an unaffected individual showed 5D4 reactivity in the corneal epithelium and stroma but not in the keratocyes on staining with 5D4 anti-KS antibody (Fig. 5A) , whereas preferential expression of sulfated KS was observed in the keratocytes and extracellular stromal matrix in case 2 (Fig. 5B) , indicating a diagnosis of MCD type II.
DNA sequencing data from multiple reads of case 1 revealed 2 heterozygous missense mutations in the coding region of the CHST6 gene (Figs. 6A, B) . The patient was found to have compound heterozygous mutations in c.529C.G (encoding an amino acid substitution of p.Arg177-Gly) ( Fig. 6A ) and in c.632G.A (encoding an amino acid substitution of p.Arg211Gln) (Fig. 6B ). The p.Arg177Gly mutation has never been reported, whereas the Arg211Gln mutation has been previously linked to MCD. 7 Because hyaline and amyloid materials were found in the subepithelial and superficial stromal deposits in case 1, blood samples were analyzed for possible mutations in the mutation hotspots (fourth and twelfth exons) of the TGFBI gene. No mutations were found in these 2 exons of the TGFBI gene.
DNA sequencing results from multiple reads of case 2 revealed 2 sequence variants in the coding region of the CHST6 gene. A single nucleotide polymorphism, c.258A.C, did not result in a protein mutation. The other homozygous missense mutation, c.557C.G, encoded a p.Pro186Arg amino acid substitution (Fig. 6C ), which has not been previously reported.
DISCUSSION
Because MCD is a disease caused by improper sulfation of KS by abnormal CHST encoded by the mutated CHST6 gene, blue mucopolysaccharide deposits within the stroma by alcian blue (a copper-containing phtalocyanine dye) staining were noted in both patients as expected. In case 1, only keratocytes along with few endothelial cells were stained with 5D4 antibody. As classified by 5D4 antisulfated KS staining patterns, this case represents MCD type IA. 5 As shown in Figure 1 , our findings are consistent with a previous report that sulfated KS in select endothelial cells and the anterior aspect of the posterior Descemet membrane can be seen in patients with MCD type IA. 4 In contrast, multiple subepithelial and stromal deposits and extracellular matrix, but not the keratocytes, stained with 5D4 antibody in case 2. These findings thus suggest a diagnosis of MCD type II in the latter case.
In addition to the discrete stromal opacities, corneas with MCD also present with a diffuse stromal haze that extends to the limbus. In contrast, the intervening spaces between stromal opacities are usually clear in granular corneal dystrophy (GCD). 1 MCD can be easily distinguished from GCD histopathologically. Mucopolysaccharide deposits of MCD stain with alcian blue, whereas hyaline deposits of GCD do not. Instead, hyaline deposits of GCD stain bright red with Masson trichrome. In addition to classic MCD findings by antisulfated KS and alcian blue staining, case 1 showed subepithelial and superficial stromal Masson trichromepositive hyaline deposits that are atypical for MCD. There were also some amyloid deposits detected by ThT in the superficial stroma. However, no mutations in the hotspots of the TGFBI gene were found in this case, suggesting that the hyalinosis and amyloidosis were secondary in nature. Secondary amyloidosis has previously been reported in Fuchs endothelial dystrophy 8 and a variety of corneal degenerations, 9, 10 but not in MCD. Taken together, this clinicopathological report is noteworthy because case 1 represents MCD with degenerative hyalinosis and amyloidosis. To the best of our knowledge, amyloid or hyaline deposits in MCD have not been previously reported. Our findings also suggest that secondary amyloidosis and hyalinosis can occur in severe MCD as a result of recurrent corneal erosions.
A plethora of disease-causing mutations in the CHST6 gene has been linked to MCD 1 in various ethnic groups. Compound heterozygous missense mutations of CHST6 (p.Arg211Gln and p.Arg177Gly) responsible for MCD were identified in case 1. The nucleotide transition, c.632G.A, causing an amino acid change, p.Arg211Gln, has been reported previously in the Vietnamese population. 7 Although other substitutions at amino acid 177, that is, pArg177Cys 11 and p.Arg177His, 12 associated with nucleic acid mutations, c.529C.T and c.530G.A, respectively, have been reported, the heterozygous mutation, p.Arg177Gly, found in case 1 is novel. To the best of our knowledge, the homozygous mutation, p.Pro186Arg, found in case 2 has never been reported previously. Moreover, this may be the first reported case of MCD in a patient of African American descent. 
